Literature Review
A literature review conducted in PubMed ® identified articles from 2008 through 2018 using the following keywords or terms: CVAD, central line, pediatric oncology, children, and cancer, as well as the MeSH (Medical Subject Headings) terms vascular access device and patient education. From the 52 articles identified, 8 discussed education strategies. Reference lists were then reviewed for additional relevant and notable studies.
Benefits of CVAD Education
This review identified the importance of CVAD education for patients and their families to improve outcomes, reduce complications, and decrease costs (Ullman, Kleidon, Cooke, & Rickard, 2017) . Outcomes, such as reduced central line-associated bloodstream infection (CLABSI) rates, increased perceived self-efficacy of parents, and reduced risk of CVAD malfunction rates, along with ability to deliver the medication using tissue plasminogen activator, were associated with standardized CVAD education (DeLa Cruz, Caillouet, & Guerrero, 2012; Furtwängler, Laux, Graf, & Simon, 2015; Rinke et al., 2013; Rosenbluth et al., 2014; Zellmer, Zimdars, & Safdar, 2016) .
Patients with cancer are particularly at risk for developing CLABSIs during the care of CVADs (Rinke et al., 2013) . Personalized and standardized education for adult patients with cancer has been shown to decrease catheter-related infections, improve patient knowledge, and decrease 
OBJECTIVES:
The goal was to investigate whether the use of a DVD education intervention reduced adverse complications and improved parent education for homecare management of CVADs for pediatric patients with cancer.
METHODS: Participants were randomized to an experimental group (DVD and nurse teaching) or a control group (nurse teaching). Postintervention evaluation included parent satisfaction and CVAD knowledge proficiency, blood infection rates, use of alteplase, and CVAD replacement.
FINDINGS: Fifty-four enrolled caregiver-patient dyads completed the study measures, with 21 dyads assigned to the control group and 33 assigned to the experimental group. Alteplase was ordered significantly less often in the experimental group. No other findings were significant. 
